Income Tax Expense (Benefit) in USD of Yubo International Biotech Ltd from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Yubo International Biotech Ltd quarterly/annual Income Tax Expense (Benefit) history and change rate from 2015 to Q3 2025.
  • Yubo International Biotech Ltd Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.000.
  • Yubo International Biotech Ltd Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $0.000.
  • Yubo International Biotech Ltd annual Income Tax Expense (Benefit) for 2024 was $0.000.
  • Yubo International Biotech Ltd annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Yubo International Biotech Ltd annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

Yubo International Biotech Ltd Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $0 $0 $0 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $0 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $0 $0 $0 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $0 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $0 $0 $0 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $0 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $0 $0 $0 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $0 $0 $0 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $0 $0 $0 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 $0 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024
Q4 2022 $0 $0 $0 01 Oct 2022 31 Dec 2022 10-K 12 Apr 2024
Q3 2022 $0 $0 $0 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 $0 $0 $0 01 Apr 2022 30 Jun 2022 10-Q 20 Nov 2023
Q1 2022 $0 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $0 $0 $0 01 Oct 2021 31 Dec 2021 10-K 14 Apr 2023
Q3 2021 $0 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 16 Nov 2022
Q2 2021 $0 $0 $0 01 Apr 2021 30 Jun 2021 10-Q 16 Nov 2022
Q1 2021 $0 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $0 $0 $0 01 Sep 2020 30 Nov 2020 10-Q 19 Jan 2021
Q3 2020 $0 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $0 $0 $0 01 Mar 2020 31 May 2020 10-Q 20 Jul 2020
Q1 2020 $0 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q4 2019 $0 $0 $0 01 Sep 2019 30 Nov 2019 10-Q 19 Jan 2021
Q3 2019 $0 $0 $0 01 Jun 2019 31 Aug 2019 10-Q 20 Oct 2020
Q2 2019 $0 $0 $0 01 Mar 2019 31 May 2019 10-Q 20 Jul 2020
Q1 2019 $0 $0 $0 01 Dec 2018 28 Feb 2019 10-KT 23 Apr 2021
Q4 2018 $0 $0 $0 01 Sep 2018 30 Nov 2018 10-Q 13 Jan 2020
Q3 2018 $0 $0 $0 01 Jun 2018 31 Aug 2018 10-Q 11 Oct 2019
Q2 2018 $0 $0 $0 01 Mar 2018 31 May 2018 10-Q 11 Jul 2019
Q1 2018 $0 $0 $0 01 Dec 2017 28 Feb 2018 10-K 12 Jun 2019
Q4 2017 $0 $0 $0 01 Sep 2017 30 Nov 2017 10-Q 11 Jan 2019
Q3 2017 $0 $0 $0 01 Jun 2017 31 Aug 2017 10-Q 12 Oct 2018
Q2 2017 $0 $0 $0 01 Mar 2017 31 May 2017 10-Q 16 Jul 2018
Q1 2017 $0 $0 01 Dec 2016 28 Feb 2017 10-K 13 Jun 2018
Q4 2016 $0 01 Sep 2016 30 Nov 2016 10-Q 16 Jan 2018
Q3 2016 $0 01 Jun 2016 31 Aug 2016 10-Q 16 Oct 2017
Q2 2016 $0 01 Mar 2016 31 May 2016 10-Q 14 Jul 2017

Yubo International Biotech Ltd Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2024
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022
2019 $0 $0 01 Mar 2019 29 Feb 2020 10-KT 23 Apr 2021
2018 $0 $0 01 Mar 2018 28 Feb 2019 10-KT 23 Apr 2021
2017 $0 $0 01 Mar 2017 28 Feb 2018 10-K 12 Jun 2019
2016 $0 $0 01 Mar 2016 28 Feb 2017 10-K 13 Jun 2018
2015 $0 01 Mar 2015 29 Feb 2016 10-K 14 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.